Recent case reports and pharmacovigilance data suggest kidney stone incidence is not universal among GLP-1 users, making personalization essential
Sobo evaluates hormone-related concerns as part of a larger medical review that may include symptoms, lab patterns, medications, thyroid function, nutrition, sleep, exercise, stress, and long-term goals
Oral semaglutide and cardiovascular outcomes in persons with type 2 diabetes, according to SGLT2i use: prespecified analyses of the SOUL randomized trial
[2] Two other pathways remain
36.8kg/m2), and lower hemoglobin A1c (HbA1c
Whether youre using a GLP-1, considering it, or trying to understand your options in a weight-focused world, Im here to help you navigate it with care, curiosity, and evidence-based guidance